Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Denies Merck Label Change

The FDA will not allow Merck to include information regarding risk of major heart problems on diabetes medication labels.

Merck / Image: Getty Images
Merck / Image: Getty Images

A recent CNBC article says the FDA rejected Merck’s application to add heart data on diabetes drug labels. The anti-diabetic medications in question, Januvia and Janumet, treat type 2 diabetes, a chronic condition that affects the way the body processes glucose. Merck submitted an application to add verbiage stating the treatments do not increase the risk of major heart problems.

The request came after a 2015 study that monitored nearly 15,000 patients showed that adding Januvia to typical care did not increase the risk of major heart problems any more than the placebo did. Results also showed no rise in hospitalization rates for heart failure, an issue that has plagued other drugs in Januvia’s class. The two Merck drugs combined for $6 billion in sales in 2016.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?